182 related articles for article (PubMed ID: 34611412)
1. MicroRNA-652 Suppresses Malignant Phenotypes in Glioblastoma Multiforme via FOXK1-Mediated AKT/mTOR Signaling Pathway [Retraction].
Onco Targets Ther; 2021; 14():4935-4936. PubMed ID: 34611412
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway.
Yang H; Song Z; Wu X; Wu Y; Liu C
Onco Targets Ther; 2019; 12():5563-5575. PubMed ID: 31371994
[TBL] [Abstract][Full Text] [Related]
3. microRNA-605 Directly Targets SOX9 to Alleviate the Aggressive Phenotypes of Glioblastoma Multiforme Cell Lines by Deactivating the PI3K/Akt Pathway [Retraction].
Onco Targets Ther; 2021; 14():4739-4740. PubMed ID: 34526778
[TBL] [Abstract][Full Text] [Related]
4. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-618 Directly Targets Metadherin mRNA to Suppress the Malignant Phenotype of Osteosarcoma Cells by Reducing PTEN-AKT Pathway Output [Retraction].
Onco Targets Ther; 2021; 14():4963-4964. PubMed ID: 34629879
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-559 Plays an Inhibitory Role in the Malignant Progression of Glioblastoma Cells by Directly Targeting Metadherin [Retraction].
Onco Targets Ther; 2021; 14():4899-4900. PubMed ID: 34594111
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-145 Inhibits the Activation of the mTOR Signaling Pathway to Suppress the Proliferation and Invasion of Invasive Pituitary Adenoma Cells by Targeting AKT3 in vivo and in vitro [Retraction].
Onco Targets Ther; 2020; 13():6851. PubMed ID: 32764974
[TBL] [Abstract][Full Text] [Related]
8. microRNA-612 Suppresses the Malignant Development of Non-Small-Cell Lung Cancer by Directly Targeting Bromodomain-Containing Protein 4 [Retraction].
Onco Targets Ther; 2021; 14():4745-4746. PubMed ID: 34526781
[TBL] [Abstract][Full Text] [Related]
9. Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer [Retraction].
Onco Targets Ther; 2023; 16():725-726. PubMed ID: 37694105
[TBL] [Abstract][Full Text] [Related]
10. Down-Regulation of SREBP via PI3K/AKT/mTOR Pathway Inhibits the Proliferation and Invasion of Non-Small-Cell Lung Cancer Cells [Retraction].
Onco Targets Ther; 2022; 15():1039-1040. PubMed ID: 36176731
[TBL] [Abstract][Full Text] [Related]
11. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
Guo X; Wang Y
Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
[TBL] [Abstract][Full Text] [Related]
12. lncRNA CRNDE is Upregulated in Glioblastoma Multiforme and Facilitates Cancer Progression Through Targeting miR-337-3p and ELMOD2 Axis [Retraction].
Onco Targets Ther; 2020; 13():12721. PubMed ID: 33328742
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-937 Inhibits the Malignant Phenotypes of Breast Cancer by Directly Targeting and Downregulating Forkhead Box Q1 [Retraction].
Onco Targets Ther; 2021; 14():4991-4992. PubMed ID: 34675539
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction].
Onco Targets Ther; 2021; 14():4937-4938. PubMed ID: 34611413
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of Immature Colon Carcinoma Transcript-1 Inhibits Proliferation of Glioblastoma Multiforme Cells through Gap 2/Mitotic Phase Arrest [Retraction].
Onco Targets Ther; 2023; 16():479-480. PubMed ID: 37396309
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-936 Targets FGF2 to Inhibit Epithelial Ovarian Cancer Aggressiveness by Deactivating the PI3K/Akt Pathway [Retraction].
Onco Targets Ther; 2021; 14():4961-4962. PubMed ID: 34675537
[TBL] [Abstract][Full Text] [Related]
17. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2159. PubMed ID: 33755958
[TBL] [Abstract][Full Text] [Related]
18. Curcumin Potentiates the Potent Antitumor Activity of ACNU Against Glioblastoma by Suppressing the PI3K/AKT and NF-κB/COX-2 Signaling Pathways [Retraction].
Onco Targets Ther; 2022; 15():1479-1480. PubMed ID: 36483451
[TBL] [Abstract][Full Text] [Related]
19. FOXK1 Promotes Proliferation and Metastasis of Gallbladder Cancer by Activating AKT/mTOR Signaling Pathway.
Wencong M; Jinghan W; Yong Y; Jianyang A; Bin L; Qingbao C; Chen L; Xiaoqing J
Front Oncol; 2020; 10():545. PubMed ID: 32363163
[TBL] [Abstract][Full Text] [Related]
20. miR-188-5p Promotes Tumor Growth by Targeting CD2AP Through PI3K/AKT/mTOR Signaling in Children with Acute Promyelocytic Leukemia [Retraction].
Onco Targets Ther; 2023; 16():1025-1026. PubMed ID: 38090111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
